Zobrazeno 1 - 10
of 156
pro vyhledávání: '"E. Board"'
Precision oncology offers a hugely exciting opportunity to personalise cancer treatments and prevention for the benefit of the individual but does present great challenges at present, both scientific and ethical. We now have the capacity to identify
Autor:
A, Lerner, K, Keshwani, A, Okines, B, Sanderson, R E, Board, M, Flynn, E, Sharkey, A, Konstantis, R, Roylance, D, Hanna, J, King, R, Murphy, F, Rehman, A E, Guppy, C, Westbury, E, Takeuchi, E, Spurrell, H K, Jayaweera, F, Raja
Publikováno v:
Clinical Oncology. 34:261-266
Fulvestrant is a selective oestrogen receptor (ER) degrader used in postmenopausal women with hormone receptor-positive advanced breast cancer. The study aim was to analyse demographics and outcomes of UK patients treated with fulvestrant monotherapy
Autor:
Alfred CP So, Ruth E Board
Publikováno v:
Melanoma Management, Vol 5, Iss 1 (2018)
Aim: We aimed to characterize the safety profile of pembrolizumab in advanced melanoma patients at our center to better reflect ‘real-world’ data on anti-PD-1 inhibitors. Materials & methods: At our institution, 58 ipilimumab-naive and 30 ipilimu
Externí odkaz:
https://doaj.org/article/f61e23173c7f4013a5eab6ff87fe832b
Autor:
Pippa Corrie, Hanhua Liu, Sarah Lawton, Rebecca Smittenaar, Bukky Juwa, David Chao, Ruth E Board
Publikováno v:
International Journal of Cancer
Immune checkpoint inhibitors (CPIs) have radically changed outcomes for patients diagnosed with metastatic melanoma globally in the last 10 years, based on evidence of overall survival (OS) benefits generated from international randomised controlled
Autor:
Pippa Corrie, B Powell, P King, R Pritchard-Jones, Ruth E Board, Martin G. Cook, Mark R. Middleton, Paul Nathan, Sally Ellis, J.M.G. Larkin, J Marsden, Marc Moncrieff, Neil Steven, Howard Peach, Paul Lorigan, Jenny L. C. Geh, Simon Rodwell, G Laitung
Publikováno v:
Journal of Plastic, Reconstructive & Aesthetic Surgery. 73:36-42
Summary Sentinel node biopsy (SNB) has been at the forefront of the surgical staging of melanoma patients for the past 15 years. The high accuracy of this prognostic staging procedure is now recognised in all international guidelines for melanoma. Ho
Autor:
Timothy J. Boring, Kurt D. Thelen, James E. Board, Jason L. De Bruin, Chad D. Lee, Seth L. Naeve, William J. Ross, Wade A. Kent, Landon L. Ries
Publikováno v:
Agronomy, Vol 8, Iss 9, p 195 (2018)
To determine if current university fertilizer rate and timing recommendations pose a limitation to high-yield corn (Zea mays subsp. mays) and soybean (Glycine max) production, this study compared annual Phosphorous (P) and Potassium (K) fertilizer ap
Externí odkaz:
https://doaj.org/article/7d82c697da4648c68d53105dc9e92cd6
Autor:
Ruth E Board, Lucy Knight, Alastair Greystoke, Fiona H Blackhall, Andrew Hughes, Caroline Dive, Malcolm Ranson
Publikováno v:
Biomarker Insights, Vol 2, Pp 307-319 (2007)
Free circulating DNA, which is thought to be derived from the primary tumour, can be detected in the blood of patients with cancer. Detection of genetic and epigenetic alteration in this tumour DNA offers a potential source of development of prognost
Externí odkaz:
https://doaj.org/article/43e5b1fa303248ce8d8c0400ab51d17e
Publikováno v:
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES. 39(1)
Individuals with cancer are at increased risk of developing new-onset diabetes mellitus and hyperglycaemia, and an estimated 20% of people with cancer already have an underlying diagnosis of diabetes mellitus. People with both cancer and diabetes may
Autor:
Michal Lotem, T. Kim Le, Jane Brokaw, Srividya Kotapati, Ana Arance, Brian Buysse, Jennifer Lord-Bessen, Frank Meiss, Laurent Mortier, Andriy Moshyk, Pippa Corrie, Stéphane Dalle, Ruth E Board, Susan D. Mathias, Kelly Oh, Ralf Gutzmer, Mark R. Middleton, Julie Scotto, Patrick Terheyden
Publikováno v:
BMC Cancer
BMC Cancer, 2021, 21 (1), pp.642. ⟨10.1186/s12885-021-08032-y⟩
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, BioMed Central, 2021, 21 (1), pp.642. ⟨10.1186/s12885-021-08032-y⟩
BMC Cancer, 2021, 21 (1), pp.642. ⟨10.1186/s12885-021-08032-y⟩
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, BioMed Central, 2021, 21 (1), pp.642. ⟨10.1186/s12885-021-08032-y⟩
Background Ipilimumab has shown long-term overall survival (OS) in patients with advanced melanoma in clinical trials, but robust real-world evidence is lacking. We present long-term outcomes from the IMAGE study (NCT01511913) in patients receiving i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a988ada341bbad946d43ff13cb331d97
https://ora.ox.ac.uk/objects/uuid:54880193-729d-489f-bed6-fb98def61d02
https://ora.ox.ac.uk/objects/uuid:54880193-729d-489f-bed6-fb98def61d02
Autor:
Martin Gore, Jonathan Smith, Sharon Capper, Myles Smith, Izhar Bagwan, Sarah Westwell, Jessica Glen, Pubudu Pathiraja, Sarah E. Coupland, Ruth E. Board, Antonia Mayberry, Miranda Payne, A. Muneer, Simon Rodwell, Susan Lalondrelle, Henry G. Smith, Ewan Wilson, Nancy Turnbull, Howard Peach, Karen Nugent
Publikováno v:
European Journal of Cancer
Ano-uro-genital (AUG) mucosal melanomas are rare cancers associated with poor outcomes and limited evidence-based management. The United Kingdom AUG mucosal melanoma guideline development group used an evidence-based systematic approach to make recom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10edc89776dd43bc00d4d0ffc20e6438
https://eprints.soton.ac.uk/443529/
https://eprints.soton.ac.uk/443529/